Link Between Serum Uric Acid to HDL Cholesterol Ratio and Overall as Well as Cardiovascular Mortality in Gout Patients
-
By
-
Xiaolin Lou
-
Rubing Guo
-
Yongtong Cao
-
Wei Zhao
-
November 19, 2025
-
Clinical Scorecard: Link Between Serum Uric Acid to HDL Cholesterol Ratio and Overall as Well as Cardiovascular Mortality in Gout Patients
At a Glance
| Category | Detail |
|---|
| Condition | Gout |
| Key Mechanisms | Uric acid promotes atherosclerosis; HDL cholesterol provides cardioprotection. |
| Target Population | Adults diagnosed with gout, particularly those with metabolic dysfunction. |
| Care Setting | Outpatient settings utilizing NHANES data. |
Key Highlights
- Gout is the most prevalent inflammatory arthritis in men and a leading cause in elderly women.
- Uric acid to HDL cholesterol ratio (UHR) is a novel biomarker for assessing cardiovascular risk.
- Higher UHR is linked to increased cardiovascular mortality in gout patients.
- Systemic inflammation from gout may accelerate cardiovascular disease progression.
- Timely intervention for metabolic dysfunction is crucial for optimizing therapeutic outcomes.
Guideline-Based Recommendations
Diagnosis
- Gout diagnosis confirmed via self-reported questionnaire.
Management
- Monitor uric acid levels and HDL cholesterol in gout patients.
Monitoring & Follow-up
- Regular follow-up on cardiovascular health and metabolic status.
Risks
- Increased risk of all-cause and cardiovascular mortality associated with high UHR.
Patient & Prescribing Data
Adults aged 20 and older diagnosed with gout.
Focus on managing uric acid levels and monitoring cardiovascular health.
Clinical Best Practices
- Utilize UHR as a composite biomarker for cardiovascular risk assessment.
- Incorporate lifestyle modifications and pharmacotherapy to manage uric acid levels.
- Conduct regular cardiovascular risk evaluations in gout patients.
References
